cycloheximide has been researched along with Gasser Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hughes, AK; Kohan, DE; Stricklett, PK | 1 |
| Karmali, MA; Monnens, LA; van de Kar, NC; van Hinsbergh, VW | 1 |
| Louise, CB; Obrig, TG | 1 |
3 other study(ies) available for cycloheximide and Gasser Syndrome
| Article | Year |
|---|---|
Shiga toxin-1 regulation of cytokine production by human proximal tubule cells.
Topics: Bacterial Toxins; Base Sequence; Cell Death; Cells, Cultured; Cycloheximide; Cytokines; DNA Primers; Hemolytic-Uremic Syndrome; Humans; Inflammation Mediators; Interleukin-1; Interleukin-6; Kidney Tubules, Proximal; Lipopolysaccharides; Protein Biosynthesis; Protein Synthesis Inhibitors; RNA, Messenger; Shiga Toxins; Tumor Necrosis Factor-alpha | 1998 |
Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome.
Topics: Bacterial Toxins; Carbohydrate Conformation; Carbohydrate Sequence; Cell Survival; Cells, Cultured; Cycloheximide; Endothelium, Vascular; Glycolipids; Hemolytic-Uremic Syndrome; Humans; Interleukin-1; Kinetics; Lipopolysaccharides; Molecular Sequence Data; Receptors, Cell Surface; Shiga Toxin 1; Time Factors; Trihexosylceramides; Tumor Necrosis Factor-alpha; Umbilical Veins | 1992 |
Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro.
Topics: Bacterial Toxins; Cell Survival; Cycloheximide; Drug Synergism; Endothelium, Vascular; Hemolytic-Uremic Syndrome; Humans; In Vitro Techniques; Interleukin-1; Shiga Toxins; Tumor Necrosis Factor-alpha | 1991 |